|
End-of-day quote
Shanghai S.E.
2026-09-11
|
5-day change | 1st Jan Change | ||
| 12.54 CNY | +10.00% |
|
+2.53% | +7.18% |
| 08-27 | Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-26 | Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement | MT |
| Market Cap | 5.08B 757M 652M 617M 559M 1.05B 72.28B 1.05B 7.33B 2.82B 36.77B 2.84B 2.78B 116B | P/E 2024 |
19.4x | P/E 2025 | 106x |
|---|---|---|---|---|---|
| Enterprise Value | 5.42B 809M 697M 660M 598M 1.12B 77.24B 1.13B 7.83B 3.01B 39.3B 3.04B 2.97B 124B | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 2.99x |
| Free-Float |
40.62% | Yield 2024 |
2.62% | Yield 2025 | 0.51% |
| 1 day | +10.00% | ||
| 1 week | +2.53% | ||
| Current month | +4.76% | ||
| 1 month | -0.87% | ||
| 3 months | -18.94% | ||
| 6 months | +7.27% | ||
| Current year | +7.18% |
| 1 week | 10.91 |  | 12.99 |
| 1 month | 10.91 | | 13.71 |
| Current year | 9.51 | | 17.46 |
| 1 year | 9.51 | | 17.46 |
| 3 years | 9.51 | | 20.34 |
| 5 years | 9.51 | | 21.28 |
| 10 years | 8.82 | | 44.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Fan Zhang
CEO | Chief Executive Officer | 41 | 2024-05-26 |
Hai Zhang
CEO | Chief Executive Officer | 41 | 2011-08-31 |
Ke Guo
DFI | Director of Finance/CFO | 39 | 2024-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Hai Zhang
CHM | Chairman | 41 | 2018-02-28 |
Qian Fan Zhang
BRD | Director/Board Member | 41 | 2018-02-28 |
Yong Jian Sheng
BRD | Director/Board Member | 52 | 2015-01-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/11/24 | Sell | Chief Executive Officer | 21,000,000 | 5.1428% | ||
| 8/2/24 | Buy | Director | 13,000 | 0.0032% | ||
| 8/5/23 | Sell | 25,000 | 0.0061% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.00% | +2.53% | -3.09% | -21.33% | 687M | |
| -0.65% | -2.93% | +47.52% | +87.34% | 1,001B | |
| -0.29% | -3.51% | +48.78% | +63.27% | 642B | |
| +0.83% | +0.26% | +16.76% | +72.52% | 451B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 340B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 263B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 247B | |
| -1.34% | -13.70% | +33.47% | +44.18% | 207B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 197B | |
| -0.75% | -4.82% | +21.94% | +86.55% | 180B | |
| Average | +0.34% | -5.17% | +18.16% | +34.69% | 352.7B | |
| Weighted average by Cap. | -0.52% | -4.33% | +29.79% | +55.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 320M 275M 261M 236M 443M 30.54B 446M 3.1B 1.19B 15.54B 1.2B 1.17B 49.09B | 1.7B 254M 219M 207M 188M 352M 24.25B 354M 2.46B 946M 12.34B 953M 932M 38.98B |
| Net income | 274M 40.85M 35.19M 33.32M 30.2M 56.67M 3.9B 56.95M 396M 152M 1.99B 153M 150M 6.27B | 46.25M 6.89M 5.94M 5.62M 5.1M 9.56M 659M 9.61M 66.81M 25.69M 335M 25.89M 25.33M 1.06B |
| Net Debt | 108M 16.05M 13.83M 13.09M 11.87M 22.26M 1.53B 22.38M 156M 59.8M 780M 60.27M 58.95M 2.46B | 349M 51.98M 44.78M 42.41M 38.44M 72.11M 4.97B 72.47M 504M 194M 2.53B 195M 191M 7.98B |
Employees
1,887
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | CN¥12.54 | +10.00% | 22,139,400 |
| 26-09-10 | CN¥11.40 | -4.36% | 7,028,035 |
| 26-09-09 | CN¥11.92 | -2.05% | 6,648,248 |
| 26-09-08 | CN¥12.17 | -4.62% | 10,484,000 |
| 26-09-07 | CN¥12.76 | +4.33% | 11,332,950 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603439 Stock
Select your edition
All financial news and data tailored to specific country editions
